Stocklytics Platform

Income Statement

publish
The Stocklytics Income Statement Screener empowers investors to focus on companies with strong financial fundamentals. Whether you’re interested in growth, profitability, or overall revenue strength, this tool helps you make informed decisions.
name
arrow_downwardRevenue Price $ Change % Change Revenue Growth % Gross Profit Operating Income Net Income EBITDA EPS Diluted
Asset logo for symbol CING
CINGCingulate
_$3.64$0.11arrow_drop_up3.11%-_-$22.75M-$23.53K-$15.56M-43.22
Asset logo for symbol MEI
MEIMethode Electronics
_$7.39$0.02arrow_drop_up0.27%-$178.80M-$112.00M-$123.30M$42.70M-2.52
SNCR
SNCRLSynchronoss Technologies, Inc. 8.375% Senior Notes due 2026
_$25.16$0.01arrow_drop_up0.07%-$121.97M-$10.64M-$34.05M$0.000.00
Asset logo for symbol YCBD
YCBDcbdMD
_$0.91-$0.03arrow_drop_down3.88%-$11.99M-$3.31M-$3.70M-$1.17M-10.90
WGSW
WGSWWGeneDx Holdings
_$0.05$0.00arrow_drop_up8.59%arrow_drop_up50.79%$194.39M-$23.21M-$52.28M$12.11M0.00
Asset logo for symbol GOSS
GOSSGossamer Bio
_$1.17$0.01arrow_drop_up1.29%-_-$183.75M-$179.81M-$61.80M-0.25
Asset logo for symbol KTRA
KTRAKintara Therapeutics
_$0.21-$7.83arrow_drop_down97.35%-_-$8.50M-$8.32M-$8.39M-11.20
JWEL
JWELJowell Global Ltd.
_$2.00$0.09arrow_drop_up5.05%-$3.27M-$10.89M-$11.46M-$10.61M-3.79
Asset logo for symbol DRMA
DRMADermata Therapeutics, Inc. Common Stock
_$0.75-$0.01arrow_drop_down2.34%-_-$8.04M-$7.79M$0.00-13.36
Asset logo for symbol GTBP
GTBPGT Biopharma
_$2.75$0.09arrow_drop_up3.37%-_-$14.36M-$13.16M$0.00-7.39
Asset logo for symbol FLO
FLOFlowers Foods
_$16.53-$0.09arrow_drop_down0.57%arrow_drop_up0.24%$2.52B$348.29M$248.11M$542.99M1.17
Asset logo for symbol OLB
OLBThe OLB Group
_$1.34$0.04arrow_drop_up3.30%arrow_drop_up0.66%$5.57M-$23.47M-$23.18M-$8.62M-6.93
LIXT
LIXTWLixte Biotechnology Holdings
_$0.03$0.030.00%-_-$5.09M-$5.08M$0.000.00
Asset logo for symbol SPRB
SPRBSpruce Biosciences
_$0.13$0.00arrow_drop_up5.04%-_-$51.99M-$47.91M-$43.18M-0.95
Asset logo for symbol SGBX
SGBXSG Blocks
_$0.59$0.00arrow_drop_up1.66%-_-$24.77M-$26.28M-$13.43M-30.00
Asset logo for symbol PLUR
PLURPluri
_$4.47-$0.03arrow_drop_down0.68%arrow_drop_up13.58%$322.00K-$22.15M-$21.34M-$21.46M-3.68
Asset logo for symbol LEN
LENLennar
_$105.20-$0.23arrow_drop_down0.21%arrow_drop_up3.52%$8.05B$4.92B$3.96B$4.94B14.31
Asset logo for symbol LOCO
LOCOEl Pollo Loco Holdings
_$9.11$0.10arrow_drop_up1.16%-$93.36M$39.79M$25.55M$56.33M0.79
Asset logo for symbol ALLO
ALLOAllogene Therapeutics
_$1.03-$0.05arrow_drop_down5.04%-_-$327.73M-$327.26M-$254.97M-1.55
Asset logo for symbol APEI
APEIAmerican Public Education
_$29.14$0.34arrow_drop_up1.16%-$307.68M-$48.30M-$47.28M$54.89M0.53
Showing 4181-4200 of 4978
Results per page:

Gain deeper insights into a company's earnings with the Stocklytics Income Statement Screener, designed to rank stocks in descending order of revenue. This tool allows you to quickly assess companies with the highest revenue and their overall income performance, providing key financial metrics for smarter investment decisions. Our screener offers detailed insights into the following income statement components: - Revenue Growth – Identify companies with impressive year-over-year growth, a critical indicator of potential future success. - Gross Profit – Analyze how well a company is managing its core production costs to generate profit. - Operating Income – Understand a company’s ability to generate profit from its primary operations, excluding non-operational activities. - Net Income – Examine the company's bottom line after all expenses, providing a clear picture of profitability. - EBITDA – Evaluate a company’s earnings before interest, taxes, depreciation, and amortization to get a sense of its overall profitability and operating performance. - EPS Diluted – Review earnings per share on a diluted basis, reflecting potential impacts of convertible securities and giving you a clearer picture of shareholder returns. By using the Stocklytics Income Statement Screener, you’ll have access to vital financial data that will help you evaluate a company's performance, profitability, and growth potential. Why the Income Statement Matters: - Revenue Performance: Understand which companies are excelling at generating top-line revenue. - Profitability: Analyze margins and earnings to identify financially strong companies. - Earnings Per Share: Evaluate companies with high earnings per share, a key metric for investors.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Take Your Investments to a Whole New Level